Clinical Trials Logo

Hypersensitivity clinical trials

View clinical trials related to Hypersensitivity.

Filter by:

NCT ID: NCT05766085 Recruiting - Clinical trials for Arterial Hypertension

Cortisol Secretion, Sensitivity and Activity and Hypertension

PRECOR
Start date: April 15, 2021
Phase:
Study type: Observational

The goal of this observational study is to evaluate, between patients with arterial hypertension and non hypertensive control group, - the prevalence of hidden hypercortisolism - the relationship between organ damage and oxidative stress level, cortisol secretion degree, sensitivity and peripheral activity

NCT ID: NCT05764200 Not yet recruiting - Insulin Sensitivity Clinical Trials

Acute Microbial Switch

Start date: July 1, 2023
Phase: N/A
Study type: Interventional

In this project the investigators will test if it is possible to measure changes in intestinal gas production after supplementation of a complex fiber mixture over a 36 hour period in both lean normoglycemic individuals and individuals with insulin resistance and/or prediabetes with overweight when compared with a placebo Changes in intestinal gas production will also be related to energy expenditure, substrate metabolism, microbial composition and related metabolites in feces, blood and urine.

NCT ID: NCT05760872 Recruiting - Cortisol Clinical Trials

Effect of MIST on Esophageal Sensitivity: Pilot Study

PilotMIST
Start date: November 4, 2021
Phase:
Study type: Observational

Influence of placing the esophageal probe on the cortisol response. Number of cortisol (non)responders and association of heart rate and subjective perception of stress with cortisol levels.

NCT ID: NCT05758532 Recruiting - Allergy Clinical Trials

Non-specific Effects of a Modified Measles Vaccination Schedule to Prevent Allergy and Unrelated Infection in Children

NEMAU
Start date: March 17, 2023
Phase: Phase 4
Study type: Interventional

The goal of this clinical trial is to evaluate the off-target/non-specific effects of the measles-mumps-rubella (MMR) vaccine in children.

NCT ID: NCT05755477 Recruiting - Clinical trials for Eosinophilic Esophagitis

Survey About the Relationship Beetween Allergic Rhinitis and Seasonal EOE Exacerbations

Start date: January 3, 2021
Phase:
Study type: Observational

Eosinophilic esophagitis (EoE) is a chronic inflammatory esophagus disease that is presented in patients with a history of recurrent dysphagia. EoE is closely related to other pathologies with an immuno-allergic etiopathogenesis such as atopic dermatitis (AD), IgE-mediated food allergy, allergic rhinitis and bronchial asthma. While the importance of the correlation between diet and food allergy has been largely demonstrated, less is known about the exact role of sensitization to aerollergens in the progression and recrudescence of symptoms. In support of this correlation there is evidence of a seasonal trend in the new diagnoses of EoE, of the possibility of the de-novo onset of the pathology following massive exposure to a specific aeroallergen and the demonstration that the degree of esophageal eosinophilia varies according to the climatic zone and the season of the year. The detailed knowledge of this correlation could clarify some aspects of the etiopathogenesis and natural history of EoE, improve and personalize the clinical-diagnostic management of affected patients and provide new therapeutic targets. Our aim is evaluating the possible existence of a correlation between the recrudescence of dysphagia symptoms and a specific month of the year and/or specific season.

NCT ID: NCT05750745 Completed - Dentin Sensitivity Clinical Trials

A Clinical Study to Evaluate the Efficacy of a Stannous Fluoride Toothpaste for the Relief of Dentine Hypersensitivity in a Chinese Population

Start date: May 8, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the efficacy of the 0.454 percentage (%) weight/weight (w/w) stannous fluoride (SnF2) toothpastes for the relief of dentine hypersensitivity (DH) in China.

NCT ID: NCT05745220 Completed - Cornea Clinical Trials

Influence of Silicone Hydrogel Contact Lens Neophyte Wear on Corneal Sensitivity

CSCL
Start date: April 8, 2023
Phase: N/A
Study type: Interventional

Soft contact lenses can affect the ocular surface and sometimes cause intolerance. The aim of this study is to measure corneal sensitivity using the Swiss Liquid Jet aesthesiometer at baseline, after one and after six weeks, in novice daily contact lens wearers.

NCT ID: NCT05744648 Completed - Carious Lesion Clinical Trials

Efficacy of Nanoparticle-incorporated Bonding Agent on Post-restorative Sensitivity

Start date: January 5, 2023
Phase: N/A
Study type: Interventional

Type of study: Randomized Clinical trial To compare post-restorative sensitivity between titania nanoparticle reinforced bonding agent and bonding agent without nanoparticles in posterior composite restorations. Participants aged 18 years and above with Class-I and Class-II Carious lesions are allocated in two groups. Group A will undergo composite restoration with Nanoparticles incorporated in bonding agent. Group B will undergo restoration without nanoparticles in bonding agent.

NCT ID: NCT05741476 Recruiting - Allergy, Peanut Clinical Trials

Safety and Efficacy Study of Viaskin Peanut in Peanut-allergic Children 4-7 Years of Age

VITESSE
Start date: February 21, 2023
Phase: Phase 3
Study type: Interventional

The primary purpose of this study is to assess the efficacy and safety of daily DBV712 250 micrograms (mcg) to induce desensitization to peanut in peanut-allergic children 4-7 years of age over a 12-month double-blind, placebo-controlled (DBPC) Treatment Period.

NCT ID: NCT05740163 Recruiting - Egg Allergy Clinical Trials

Oral Immunotherapy for Egg Allergy in Children Aged 6 to 16

Start date: December 30, 2019
Phase: N/A
Study type: Interventional

The aim of the study is to determine the efficacy of a 12-month egg oral immunotherapy (OIT) protocol with a cooked whole egg product including yolk and egg white. Study hypothesis: With this method the risk for severe allergic reaction to egg protein is reduced and the diet can partly or completely be normalized.